These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 19266144)

  • 1. Fatigue, pain and muscle weakness are frequent after Guillain-Barré syndrome and poliomyelitis.
    Rekand T; Gramstad A; Vedeler CA
    J Neurol; 2009 Mar; 256(3):349-54. PubMed ID: 19266144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Residual neuropathy in long-term population-based follow-up of Guillain-Barré syndrome.
    Dornonville de la Cour C; Jakobsen J
    Neurology; 2005 Jan; 64(2):246-53. PubMed ID: 15668421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distal limb weakness phenotype of Guillain-Barré syndrome.
    Koga M; Kishi M; Fukusako T; Kanda T
    J Neurol Sci; 2018 Sep; 392():83-88. PubMed ID: 30031173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual fatigue is independent of antecedent events and disease severity in Guillain-Barré syndrome.
    Garssen MP; Van Koningsveld R; Van Doorn PA
    J Neurol; 2006 Sep; 253(9):1143-6. PubMed ID: 16998652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mild Guillain-Barré syndrome.
    Green DM; Ropper AH
    Arch Neurol; 2001 Jul; 58(7):1098-101. PubMed ID: 11448299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-year follow-up outcomes of adult patients with Guillain-Barré Syndrome after rehabilitation.
    Uz FB; Uz C; Karaahmet OZ
    Malawi Med J; 2023 Sep; 35(3):156-162. PubMed ID: 38362288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of long-term health-related quality of life in Guillain-Barré syndrome: A hospital-based study.
    Khedr EM; Mahmoud DM; Ahmed GK; Haridy NA
    Clin Neurol Neurosurg; 2023 Dec; 235():108026. PubMed ID: 37913589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pain in Guillain-Barre syndrome: a long-term follow-up study.
    Ruts L; Drenthen J; Jongen JL; Hop WC; Visser GH; Jacobs BC; van Doorn PA;
    Neurology; 2010 Oct; 75(16):1439-47. PubMed ID: 20861454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there a need for long-term follow-up in chronic idiopathic polyneuropathy?
    Rudolph T; Larsen JP; Farbu E
    Acta Neurol Scand; 2009 Nov; 120(5):347-52. PubMed ID: 19744135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome in children with Guillain-Barré syndrome.
    Vajsar J; Fehlings D; Stephens D
    J Pediatr; 2003 Mar; 142(3):305-9. PubMed ID: 12640380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perceived disability, fatigue, pain and measured isometric muscle strength in patients with post-polio symptoms.
    Lygren H; Jones K; Grenstad T; Dreyer V; Farbu E; Rekand T
    Physiother Res Int; 2007 Mar; 12(1):39-49. PubMed ID: 17432393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nerve conduction studies in relation to residual fatigue in Guillain-Barré syndrome.
    Garssen MP; van Doorn PA; Visser GH
    J Neurol; 2006 Jul; 253(7):851-6. PubMed ID: 16845568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Six-month prospective study of quality of life in Guillain-Barre syndrome.
    Djordjevic G; Stojanov A; Bozovic I; Berisavac I; Arsenijevic M; Lukic Rajic S; Dominovic Kovacevic A; Jovanovic D; Basta I; Peric S
    Acta Neurol Scand; 2020 Mar; 141(3):236-241. PubMed ID: 31705530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lifestyle and late effects after poliomyelitis. A risk factor study of two populations.
    Rekand T; Kõrv J; Farbu E; Roose M; Gilhus NE; Langeland N; Aarli JA
    Acta Neurol Scand; 2004 Feb; 109(2):120-5. PubMed ID: 14705974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding residuals in Guillain-Barre syndrome.
    Gregory R; Kaplan L
    Nurs N Z; 2004 Aug; 10(7):16-7. PubMed ID: 15460647
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term outcomes of Guillain-Barré syndrome possibly associated with Zika virus infection.
    Walteros DM; Soares J; Styczynski AR; Abrams JY; Galindo-Buitrago JI; Acosta-Reyes J; Bravo-Ribero E; Arteta ZE; Solano-Sanchez A; Prieto FE; Gonzalez-Duarte M; Navarro-Lechuga E; Salinas JL; Belay ED; Schonberger LB; Damon IK; Ospina ML; Sejvar JJ
    PLoS One; 2019; 14(8):e0220049. PubMed ID: 31369576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrotic syndrome and Guillan-Barré Syndrome: a rare association in child.
    Bouyahia O; Khelifi I; Gharsallah L; Harzallah K; Mrad SM; Ghargah T; Boukthir S; Azza Sel G
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):135-7. PubMed ID: 20061709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of Guillain-Barré syndrome in children.
    Roodbol J; de Wit MC; Aarsen FK; Catsman-Berrevoets CE; Jacobs BC
    J Peripher Nerv Syst; 2014 Jun; 19(2):121-6. PubMed ID: 24863162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long-term functional status in patients with Guillain-Barré syndrome.
    Rudolph T; Larsen JP; Farbu E
    Eur J Neurol; 2008 Dec; 15(12):1332-7. PubMed ID: 19049550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term sensory deficit after Guillain-Barré syndrome.
    Bernsen RA; Jager AE; Schmitz PI; van der Meché FG
    J Neurol; 2001 Jun; 248(6):483-6. PubMed ID: 11499638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.